The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
12 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $8,813,135 in first-year total cost, median $608,502.
Most frequent study sections
- Special Emphasis Panel[ZRG1 VH-D (55)]11
- Special Emphasis Panel[ZRG1-VH-D(55)R]1
Most frequent institutions
- UNIVERSITY OF VIRGINIA2
- VITALANT2
- ALBERT EINSTEIN COLLEGE OF MEDICINE1
- BLOODWORKS1
- CHILDREN'S HOSP OF PHILADELPHIA1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2020 | Interactions between the ADORA2b/Sphk1axis and the AE1-Hb switch in red blood cell aging in vivo and in vitro1R01HL149714-01 | D'ALESSANDRO, ANGELO | UNIVERSITY OF COLORADO DENVER, CO | $730,338 | ZRG1 |
| 2020 | Targeting Dyrk1a to Promote Donor-independent Platelet Production1R01HL149667-01 | GOLDFARB, ADAM N. | UNIVERSITY OF VIRGINIA, VA | $714,564 | ZRG1 |
| 2020 | Impact of Anemia and Its Treatment on Gut Injury in Preterm Infants1R01HL138714-01A1 | JOSEPHSON, CASSANDRA DSTOWELL, SEAN R | EMORY UNIVERSITY, GA | $612,219 | ZRG1 |
| 2020 | Transfusion-related immunomodulation influences infectious disease outcomes1R01HL153073-01 | SIMMONS, GRAHAM | VITALANT, AZ | $604,784 | ZRG1 |
| 2020 | Role of TRPM8 in Cold-stored Platelet Transfusions1R01HL153072-01 | STOLLA, MORITZ | BLOODWORKS, WA | $507,279 | ZRG1 |
| 2020 | The Therapeutic Potential of Cold Stored Platelets in Regulating Vascular Instability in Trauma1R01HL147880-01A1 | PATI, SHIBANI | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $403,750 | ZRG1 |
| 2019 | The Impact of Oxidative Stress on Erythocyte Biology1R01HL148151-01 | D'ALESSANDRO, ANGELOKARAFIN, MATTHEW SSPITALNIK, STEVEN LZIMRING, JAMES C. | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $2,233,538 | ZRG1 |
| 2019 | RH genotype matched red cell transfusions for patients with sickle cell disease1R01HL147879-01 | CHOU, STELLA T | CHILDREN'S HOSP OF PHILADELPHIA, PA | $853,809 | ZRG1 |
| 2019 | The impact of illness and medical treatments on the alloantibody response to platelet transfusion1R01HL144501-01A1 | JACKMAN, RACHAEL PERETZ | VITALANT, AZ | $756,531 | ZRG1 |
| 2019 | Immunobiology of Alloimmunization by Platelet Transfusion1R01HL144428-01 | ZIMRING, JAMES C. | UNIVERSITY OF VIRGINIA, VA | $550,586 | ZRG1 |
| 2019 | Patrolling Monocytes in Sickle Pain Crisis and following Transfusion1R01HL145451-01A1 | YAZDANBAKHSH, KARINA | NEW YORK BLOOD CENTER, NY | $445,000 | ZRG1 |
| 2019 | Maximizing transfusion efficacy through nitric oxide enhancement strategies1R56HL148005-01 | FRIEDMAN, JOEL MINTAGLIETTA, MARCOS | ALBERT EINSTEIN COLLEGE OF MEDICINE, NY | $400,737 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.